Skip to main content
Novolog (pharm-up 1966) Ltd. logo

Novolog (pharm-up 1966) Ltd. — Investor Relations & Filings

Ticker · NVLG ISIN · IL0011401515 TA Wholesale and retail trade
Open in API
Filings indexed 28 across all filing types
Latest filing 2023-11-20 Investor Presentation
Country IL Israel
Listing TA NVLG

About Novolog (pharm-up 1966) Ltd.

https://www.novolog.co.il/en

Novolog (Pharm-Up 1966) Ltd. is a healthcare services company that operates through three primary divisions: Logistics, Healthcare, and Digital Health. The Logistics division functions as a strategic partner for global pharmaceutical companies, providing advanced health logistics services. The Healthcare division focuses on improving the quality of care by offering services such as home healthcare and supplying medical devices to healthcare institutions and patients. The Digital Health division develops and markets platforms that provide patients with access to treatment information, scheduling, and communication with care providers, alongside digital tools for physicians.

Recent filings

Filing Released Lang Actions
Presentation - Q3 2023
Investor Presentation Classification · 1% confidence The document is a presentation titled 'Q3-2023 Results' for Novolog Group. It contains financial highlights, segment performance, and strategic information. While it presents financial data, it is structured as a slide deck for investors rather than a formal statutory quarterly report. According to the filing definitions, this fits the 'Investor Presentation' category as it is a detailed presentation for investors focusing on financials, strategy, and market position. Q3 2023
2023-11-20 English
Presentation - Q3 2023
Regulatory Filings Classification · 1% confidence The document text is very short (2589 characters) and contains structured information typical of a regulatory filing announcement, including dates, company identifiers, and references to attached files (e.g., '����� ���� *����_�������_�����_isa.pdf*'). The title section mentions '���� ������� ������� - ������ 2023' (which translates roughly to 'Regulatory Report - December 2023' or similar contextually). Crucially, the document structure strongly suggests it is an announcement *about* a filing rather than the full report itself. Given the context of regulatory filings in Israel (indicated by 'www.isa.gov.il'), and the short length combined with the announcement nature, this fits best as a general Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA). Since it doesn't explicitly state 'report attached' but rather presents filing metadata and links, RNS is a suitable general classification for miscellaneous regulatory disclosures that don't fit the specific financial report codes (10-K, IR, ER). However, the presence of structured data points like '���� ������' (Report Title) and the reference to a specific PDF suggests it is announcing the publication of a specific document. Given the options, and the lack of specific financial reporting keywords (like 'balance sheet' or 'income statement'), RNS is the most appropriate fallback for a general regulatory disclosure announcement.
2023-11-20 Russian
Investor presentation-Q2-2023 Results
Earnings Release Classification · 1% confidence The document is explicitly titled "Q2-2023 Results" and contains detailed financial tables comparing H1-2023/Q2-2023 results against H1-2022/Q2-2022, including Revenues, Gross Profit, Operating Profit, Net Profit, and Adjusted EBITDA. This structure is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it presents the key financial highlights and performance summary for the second quarter, it fits the definition of an Earnings Release (ER) which is the initial announcement of periodical financial results. While it contains substantial detail, the focus on quarterly results and the presentation format suggest an ER rather than the comprehensive, statutory Interim Report (IR), although the line is often blurred. Given the title 'Q2-2023 Results' and the presentation format, ER is the most appropriate classification for the initial release of these figures. Q2 2023
2023-08-22 English
Investor presentation-Q2-2023 Results
Regulatory Filings Classification · 1% confidence The document text is very short (2580 characters) and contains a title that translates roughly to 'NOVOLOG (PHARM-UP 1966) LTD - August 2023'. It includes metadata fields like filing date (22/08/2023) and references to regulatory bodies (ISA, TASE). Crucially, it contains placeholders and links/references to an attached file ('����� ���� *����_��������_�������_isa.pdf*') and lists items under a heading that suggests a summary or announcement ('**���� ������� ������� ����� ��� ������:**'). This structure strongly indicates an announcement about the publication of a report rather than the full report itself. Given the context of regulatory filings and the short length, this fits the definition of a Report Publication Announcement (RPA).
2023-08-22 Russian
INVESTORS PRESENTATION-MAY 2023
Investor Presentation Classification · 1% confidence The document is a presentation titled 'Q1-2023 Results' for Novolog Group. It contains financial highlights, segment performance, and strategic information. While it discusses financial results, it is structured as a slide deck for investors rather than a formal statutory quarterly report. According to the filing definitions, detailed presentations for investors focusing on financials and strategy are classified as Investor Presentations (IP). Q1 2023
2023-05-30 English
INVESTORS PRESENTATION-MAY 2023
Notice of Dividend Amount Classification · 1% confidence The document text is very short (2572 characters) and contains a title that translates to 'NOVOLOG (PHARM-UP 1966) LTD - May 2023' and a bolded section labeled '**Report Title:** ***Dividend Distribution Announcement - May 2023***'. It also includes a date of publication (30/05/2023) and references to filing with regulatory bodies (ISA, TASE). Crucially, it lists dividend details (though the values are redacted) and provides a link to a PDF file. This structure strongly suggests an official announcement regarding a corporate action (dividend distribution) rather than the full financial report itself (like 10-K or IR). Since 'Notice of Dividend Amount' (DIV) is a specific category for dividend details, and this document appears to be the official notice/announcement of that distribution, DIV is the most appropriate classification. It is not a general regulatory filing (RNS) because a more specific category exists.
2023-05-30 Russian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.